ArticleResuscitation plus2025
A survey of Advanced Life Support practices in countries implementing the European Resuscitation Council guidelines.
Article in Resuscitation plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The 2025 European Resuscitation Council (ERC) Advanced Life Support (ALS) Guidelines writing group aims to produce inclusive guidelines enabling implementation by National Resuscitation Councils (NRC) based on local resources and practices. We aimed to describe ALS practices across NRCs to further inform the 2025 ERC ALS Guidelines. Methods: A cross-sectional survey was conducted to assess clinical practices for defibrillation, drugs and airway management during ALS in out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) amongst countries represented by an NRC. NRCs were invited to suggest practices for consideration in the 2025 ERC ALS Guidelines. Results: Among 31 NRCs, 30 (96.8 %) provided data. Defibrillation pads were used for OHCA in 21 (70 %) and for IHCA in 15 (50 %) of countries, while paddles were reported by 3 (10 %) and 6 (20 %) for OHCA and IHCA, respectively. Most NRCs reported not using a pre-charging strategy (23 [76.7 %] OHCA; 26 [86.7 %] IHCA). Amiodarone was the primary antiarrhythmic (26 [89.7 %], OHCA; 28 [93.3 %], IHCA), and adrenaline was the primary vasopressor (27 [90 %], OHCA; 29 [96.7 %], IHCA). Airway management practices varied, 12 (41.4 %) reported supraglottic airway devices as the primary choice for OHCA and 1 (3.3 %) for IHCA, while 22 (73.3 %) reported tracheal tubes for IHCA and only 9 (31 %) for OHCA. Open-ended responses emphasised the importance of guidance in low-resource settings. Conclusion: Current ALS practices vary across countries, and between OHCA and IHCA settings with a need to consider low-resource settings. Understanding these practices has implications for guideline development and research planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.